KIT and gastrointestinal stromal tumor: Unlike the MAPK/ERK pathway, SHP2 inhibition rarely affected STAT1/3 phosphorylation (Figure S13), further underscoring the specific role of SHP2 in regulation of MAPK/ERK pathway in KIT‐mutant GIST.